Literature DB >> 15235765

Role of sex steroids in the regulation of bone morphology in men. The MINOS study.

P Szulc1, K Uusi-Rasi, B Claustrat, F Marchand, T J Beck, P D Delmas.   

Abstract

In ageing men, skeletal fragility is associated with reduced cortical thickness and decreased bone density. To better understand the role of testosterone and 17beta-estradiol regarding these characteristics of skeletal fragility, we correlated their circulating levels with the estimates of mechanical bone properties derived from areal bone mineral density (aBMD) measured by DXA. External diameter and BMD were used to estimate cortical thickness, cross-sectional area (CSA), section modulus, buckling ratio and strength index of the femoral neck and distal radius on 760 men aged 40-85 years. The 17beta-estradiol level was an independent positive determinant of CSA, aBMD and estimated cortical thickness of both bones. In multivariate models adjusted for age, body weight, height, lean body mass and testosterone concentration, men in the lowest quartile of 17beta-estradiol had lower CSA at the femoral neck (4.8%, P<0.001) and distal radius (3.6%, P<0.01) compared with men in the highest quartile. They had also thinner cortical bone at the femoral neck and distal radius (4.8%, P<0.001 and 4.6%, P<0.001, respectively). Furthermore 17beta-estradiol had a negative association with indices of cortical instability (buckling ratio) and a positive association with bending strength (section modulus, strength index) both at femoral neck and radius. Men in the lowest quartile of 17beta-estradiol had higher buckling ratios (femoral neck 4.8%, P<0.002; radius 5.1%, P<0.005), lower strength index (femoral neck 8.5%, P<0.001, radius 6.1%, P<0.01) and greater section modulus at the femoral neck. However, there were no between-quartile differences in external diameter in any bone sites. Similar, even though somewhat smaller, between-quartile differences were found for bioavailable 17beta-estradiol. Neither total testosterone nor apparent free testosterone concentration was associated with any bone variables after adjusting for age, body weight, body height, and lean body mass and 17beta-estradiol level. In conclusion, in elderly men, low concentration of 17beta-estradiol (total and bioavailable) was associated with a decreased cortical thickness and with a deterioration of biomechanical parameters of long bones (lower section modulus and strength index, higher buckling ratio).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15235765     DOI: 10.1007/s00198-004-1635-0

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  43 in total

1.  Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men.

Authors:  S Khosla; L J Melton; E J Atkinson; W M O'Fallon
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

2.  Androgens, estrogens, and bone turnover in men.

Authors:  Sundeep Khosla; B L Riggs
Journal:  J Clin Endocrinol Metab       Date:  2003-05       Impact factor: 5.958

3.  New approaches for interpreting projected bone densitometry data.

Authors:  D R Carter; M L Bouxsein; R Marcus
Journal:  J Bone Miner Res       Date:  1992-02       Impact factor: 6.741

4.  Identification of androgen receptors in normal human osteoblast-like cells.

Authors:  D S Colvard; E F Eriksen; P E Keeting; E M Wilson; D B Lubahn; F S French; B L Riggs; T C Spelsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

5.  The apparent free testosterone concentration, an index of androgenicity.

Authors:  A Vermeulen; T Stoïca; L Verdonck
Journal:  J Clin Endocrinol Metab       Date:  1971-11       Impact factor: 5.958

6.  Effects of androgens on the insulin-like growth factor system in an androgen-responsive human osteoblastic cell line.

Authors:  F Gori; L C Hofbauer; C A Conover; S Khosla
Journal:  Endocrinology       Date:  1999-12       Impact factor: 4.736

7.  Cross-sectional geometrical properties and bone mineral contents of the human radius and ulna.

Authors:  E S Hsu; A G Patwardhan; K P Meade; T R Light; W R Martin
Journal:  J Biomech       Date:  1993-11       Impact factor: 2.712

8.  Estradiol, androstenedione, testosterone, and dehydroepiandrosterone sulfate in the ovarian and peripheral blood of postmenopausal patients with and without endometrial cancer.

Authors:  A G Bremond; B Claustrat; R C Rudigoz; P Seffert; J Corniau
Journal:  Gynecol Oncol       Date:  1982-08       Impact factor: 5.482

9.  Skeletal effects of estrogen deficiency as induced by an aromatase inhibitor in an aged male rat model.

Authors:  D Vanderschueren; S Boonen; A G Ederveen; R de Coster; E Van Herck; K Moermans; L Vandenput; A Verstuyf; R Bouillon
Journal:  Bone       Date:  2000-11       Impact factor: 4.398

10.  Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female rats.

Authors:  R T Turner; G K Wakley; K S Hannon
Journal:  J Orthop Res       Date:  1990-07       Impact factor: 3.494

View more
  18 in total

1.  Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone.

Authors:  A Bojesen; N Birkebæk; K Kristensen; L Heickendorff; L Mosekilde; J S Christiansen; C H Gravholt
Journal:  Osteoporos Int       Date:  2010-07-24       Impact factor: 4.507

2.  Sex steroid hormone levels and body composition in men.

Authors:  Margaret A Gates; Rania A Mekary; Gretchen R Chiu; Eric L Ding; Gary A Wittert; Andre B Araujo
Journal:  J Clin Endocrinol Metab       Date:  2013-04-26       Impact factor: 5.958

3.  Inter-sex differences in structural properties of aging femora: implications on differential bone fragility: a cadaver study.

Authors:  Danijela Djonic; Petar Milovanovic; Slobodan Nikolic; Miomira Ivovic; Jelena Marinkovic; Thomas Beck; Marija Djuric
Journal:  J Bone Miner Metab       Date:  2010-12-04       Impact factor: 2.626

4.  Oxytocin and bone status in men: analysis of the MINOS cohort.

Authors:  V Breuil; E Fontas; R Chapurlat; P Panaia-Ferrari; H B Yahia; S Faure; L Euller-Ziegler; E Z Amri; P Szulc
Journal:  Osteoporos Int       Date:  2015-06-25       Impact factor: 4.507

5.  Poor bone microarchitecture in older men with impaired physical performance--the STRAMBO study.

Authors:  S Blaizot; S Boutroy; N Vilayphiou; S Boonen; R Chapurlat; P Szulc
Journal:  Osteoporos Int       Date:  2012-12       Impact factor: 4.507

6.  Biochemical markers of bone turnover, hip bone loss, and fracture in older men: the MrOS study.

Authors:  Douglas C Bauer; Patrick Garnero; Stephanie L Harrison; Jane A Cauley; Richard Eastell; Kris E Ensrud; Eric Orwoll
Journal:  J Bone Miner Res       Date:  2009-12       Impact factor: 6.741

7.  Correlations between serum testosterone, estradiol, and sex hormone-binding globulin and bone mineral density in a diverse sample of men.

Authors:  Andre B Araujo; Thomas G Travison; Benjamin Z Leder; John B McKinlay
Journal:  J Clin Endocrinol Metab       Date:  2008-03-25       Impact factor: 5.958

8.  Relation between serum testosterone, serum estradiol, sex hormone-binding globulin, and geometrical measures of adult male proximal femur strength.

Authors:  Thomas G Travison; Andre B Araujo; Thomas J Beck; Rachel E Williams; Richard V Clark; Benjamin Z Leder; John B McKinlay
Journal:  J Clin Endocrinol Metab       Date:  2008-12-23       Impact factor: 5.958

Review 9.  Sex steroid actions in male bone.

Authors:  Dirk Vanderschueren; Michaël R Laurent; Frank Claessens; Evelien Gielen; Marie K Lagerquist; Liesbeth Vandenput; Anna E Börjesson; Claes Ohlsson
Journal:  Endocr Rev       Date:  2014-09-09       Impact factor: 19.871

10.  Familial resemblance of bone turnover rate in men aged 40 and over-the MINOS study.

Authors:  Hoda Nagy; Clément Feyt; Roland Chapurlat; Pawel Szulc
Journal:  J Bone Miner Metab       Date:  2012-11-23       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.